As the cancer day care centre at AIIMS, Delhi, spills over, families hope decentralised treatment will cut costs, minimise ...

The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

The new drug is meant to treat specific types of advanced breast cancer which are resistant to hormone therapy.

The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.

You are braver than you believe, stronger than you seem, smarter than you think, and twice as beautiful as you’d ever imagined. Cancer remains one of the most formidable health challenges ...

Trusted resource of information on Breast Cancer that includes articles, news, videos, animations, quizzes, health calculators and drugs.

Nearly 700,000 women across the country will take part in a world-leading trial to test how cutting-edge AI tools can be used to catch breast cancer cases earlier, the Department of Health and Social ...

The World Health Organisation, WHO, has warned of a rising cancer burden. Breast cancer remains the most common cancer among ...

Roxy Jacenko has revealed a new health scare almost 10 years after battling breast cancer. The PR mogul, 44, shared a video ...

As our understanding of cancer has evolved, so too has the promise of personalized oncology — treatment tailored to each ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which ...